Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.37 USD | +3.59% | +5.01% | -22.32% |
May. 07 | Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M | MT |
May. 07 | Transcript : Veracyte, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 405M | Sales 2025 * | 448M | Capitalization | 1.63B |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | - | EV / Sales 2024 * | 3.48 x |
Net cash position 2024 * | 226M | Net cash position 2025 * | 291M | EV / Sales 2025 * | 3 x |
P/E ratio 2024 * |
-89
x | P/E ratio 2025 * |
-
| Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.15% |
Latest transcript on Veracyte, Inc.
1 day | +3.59% | ||
1 week | +5.01% | ||
Current month | +9.20% | ||
1 month | +3.19% | ||
3 months | -16.43% | ||
6 months | -3.74% | ||
Current year | -22.32% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 21-05-31 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 21-07-18 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 08-01-31 |
Robert Epstein
CHM | Chairman | 69 | 15-01-11 |
Karin Eastham
BRD | Director/Board Member | 74 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 21.37 | +3.59% | 1,054,502 |
24-05-09 | 20.63 | +2.53% | 746,995 |
24-05-08 | 20.12 | -4.33% | 955,094 |
24-05-07 | 21.03 | +0.53% | 752,942 |
24-05-06 | 20.92 | +2.80% | 515,522 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.32% | 1.63B | |
-27.67% | 9.87B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M | |
+12.46% | 219M |
- Stock Market
- Equities
- VCYT Stock